The University Hospital of Montpellier (CHUM) is the tertiary referral centre of the Region. CHUM is a university hospital with 800 beds and recognized as EULAR centre of excellence in rheumatology. The Institute for Regenerative Medicine and Biotherapy (IRMB) is associated with CHUM, the National Institute of Health and Medical Research, and the University of Montpellier. IRMB gathers scientific and medical expertise on regenerative medicine and innovative immunotherapies. The objectives of IRMB are to increase the knowledge of stem cell biology, interactions between stem cells and immune cells, as well as the role of epigenetics mechanisms in chronic and age related diseases.
Role: CHUM will be involved in the multidimensional analysis for patient stratification and in the implementation of the CDSMP in France. CHUM will also contribute to the assessment and nalysis of the results of EFFICHRONIC.
Work Package Leader: WP7.
Prof Christian Jorgensen. He has extensive experience in stem cells trials in rheumatology, as well as data analysis and assessment.